Viraj Lavingia
Medical Oncologist
Ahmedabad,GJ
Summary
I am a dedicated Medical Oncologist specializing in gastrointestinal cancers, with a proven track record in leading advanced clinical trials and pioneering research in oncology. As the Head of the Department of Medical Oncology at Shalby Hospitals, Ahmedabad, I bring a strong focus on integrating cutting-edge therapies into patient care. My strengths include a deep understanding of precision medicine and mentoring the next generation of oncologists. I am passionate about driving innovation in cancer treatment and improving patient outcomes through personalized, evidence-based approaches.
Overview
16
16
years of professional experience
4
4
Certifications
Work History
Dept Head, Medical Oncology
Shalby Hospitals
10.2023 - Current
- Conducted 1st SCRI-CON with pan India Shalby Hospitals, with over 150 faculties participating over two days (6th & 7Th July, 2024)
- Current DNB guide for 2 students for the year 2024
- Experience in clinical trials: Site PI for CORAL study (NCT03564938), EMERALD-3 (NCT05301842)
- Site PI for 3 phase IA studies (first-in-human) from Lupin (LNP7457, LNP3693 & LNP8701) – ongoing
- Co-PI for several other clinical trials (NCT03682068; NCT04736199, CTRI/2018/07/014885, CTRI/2018/07/014881)
Director GI Medical Oncology and Admin head for Department of Medical Oncology
HCG Cancer Centre
04.2018 - 09.2023
- Managed GI Medical Oncology department and served as the Admin head
- Consultant Medical Oncologist (Gastrointestinal services).
- Successfully conducted dedicated GI oncology scientific meetings (Twice – September 2018 & September 2019) attended by more than 150 oncologists across the country
- 3rd & 4th edition of GI conference held virtually September 2020 & September 2021 respectively during pandemic
- 5th edition hosted more than 200 national faculties held in Ahmedabad on 3rd & 4th September 2022
- Co-guide for DNB Medical Oncology since 2018
- 6 theses accepted so far in DNB
- Several invited lectures/seminars at national scientific meetings
- Invited talk on gastric cancer in Nepal at SAARC meeting, 2019
- Presented real world data on Durvalumab for BTC as a poster at ESMO GI23
- Participated in multiple advisory board meetings abroad across various industries, including pharmaceuticals and diagnostics
Consultant Medical Oncologist
Apollo CBCC
11.2017 - 05.2018
- Provided medical oncology consultation services.
DNB fellow
Apollo hospital
07.2014 - 06.2017
- Fellowship in Medical Oncology
- Team management, supervision of junior doctors, managing indoor patients, seeing outdoor/OPD patients, managing emergencies
- Managing Chemotherapy and Transfusions, active participation in treatment decisions in a MDT meeting for any GI malignancy especially CRC.
Senior Registrar, Medical Oncology
Fortis
12.2013 - 06.2014
- Worked with Dr
- Boman Dhabhar.
DNB scholar, Internal Medicine
Breach Candy Hospital
02.2009 - 02.2012
- Scholarship in Internal Medicine
- Worked with Dr
- Farookh Udwadia.
Medical Officer, Hemato-Oncology
Lilavati Hospital
06.2008 - 01.2009
- Worked with Dr
- Boman Dhabhar & Dr
- MB Agarwal.
Education
DNB Medical Oncology -
Apollo Hospital
DNB Internal Medicine - undefined
Breach Candy Hospital
MBBS - undefined
Smt. NHL Municipal Medical College
Certification
UICC (ICRETT) fellow, City of Hope, Duarte USA (June 2016)
Affiliations
- ASCO
- ESMO
- NANETS
- IHPBA
- INASL
- ISMPO
- IJMPO – associate editor for GI cancers
Medicalcouncilregistration
Gujarat, 33099
Research (orcid.org/0000-0003-1981-2693)
- Evaluation and Management of Unresectable Hepatocellular Carcinoma: Multidisciplinary Indian Consensus Statements from a Delphi Panel – SAJC 2024 July; DOI: 10.1055/s-0044-1788569
- Adjuvant therapy may improve overall survival in high-risk periampullary adenocarcinomas patients - A match-pair analysis from a multi-institutional cohort study (The MIPPAP study) – HPB (oxford). 2024 July; doi: 10.1016/j.hpb.2024.06.010
- Systemic therapy for Pancreatic Neuroendocrine Tumors – Indian J Surg Oncol 2024 May, doi: 10.1007/s13193-024-01908-y.
- To be or not to be - J Psychosoc Oncol. 2024 Mar 19:1-3. doi: 10.1080/07347332.2024.2330418
- Localized Rectal Cancer: Indian Consensus and Guidelines. IJMPO: Feb 2024, https://doi.org/10.1055/s-0043-1777865.
- The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy. Cureus 15(9): e44529. September 2023, doi:10.7759/cureus.44529.
- Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) - Results from the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP) Study – Journal of Gastrointestinal Oncology, June 2023 – doi: 10.1007/s12029-023-00936-1.
- HER2 ‘neu’ promise for mCRC – Review article in International Journal of Molecular and Immuno Oncology, February 2023 - doi: 10.25259/IJMIO_30_2022
- Addition of trastuzumab emtansine (T-DM1) in a human epidermal growth factor receptor 2-overexpressed metastatic carcinoma of the gallbladder patient to enhance survival: A case study. SAGE Open Med Case Rep. 2022 Nov 27;10:2050313X221137447. doi: 10.1177/2050313X221137447.
- Time for colorectal cancer screening in India! - Editorial in Indian Journal of Cancer, July 2021 - doi:10.4103/ijc.ijc_918_21
- Systemic Treatment for Metastatic Colorectal Cancer in the Era of Precision Medicine – Review article in Journal of Surgical Oncology, April 2019 – doi: 10.1002/jso.25421
- Impressive response to dual mutant intrahepatic cholangiocarcinoma – Journal of Gastrointestinal Oncology, December 2016 – doi: 10.21037/jgo.2016.09.13
- Pulmonary artery thrombosis mimicking disease progression in metastatic renal cell carcinoma while on sunitinib. Indian J Cancer 2016 – doi: 10.4103/0019-509X.180852
- PRES, the most uncommon side effect of one of the commonest chemotherapy regimen, FOLFOX. Apollo Medicine March 2015; doi: 10.1016/j.apme.2015.02.002
- Book chapter – Recent clinical trials in gastric cancer, in the book “Update in Oncology for Physicians 2024”
References
- Dr. Boman Dhabhar, Mumbai
- Dr. Vijay Anand Reddy, Hyderabad
- Dr. Fakih Marwan, City of Hope, USA
- Dr. Crystal Denlinger, Fox Chase Cancer Center, USA
- Dr. Bhawna Sirohi, Balco, Chhattisgarh, India
Work Availability
monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse
Timeline
Dept Head, Medical Oncology
Shalby Hospitals
10.2023 - Current
Director GI Medical Oncology and Admin head for Department of Medical Oncology
HCG Cancer Centre
04.2018 - 09.2023
Consultant Medical Oncologist
Apollo CBCC
11.2017 - 05.2018
DNB fellow
Apollo hospital
07.2014 - 06.2017
Senior Registrar, Medical Oncology
Fortis
12.2013 - 06.2014
DNB scholar, Internal Medicine
Breach Candy Hospital
02.2009 - 02.2012
Medical Officer, Hemato-Oncology
Lilavati Hospital
06.2008 - 01.2009
DNB Medical Oncology -
Apollo Hospital
DNB Internal Medicine - undefined
Breach Candy Hospital
MBBS - undefined
Smt. NHL Municipal Medical College
Similar Profiles
DHARMIL LIFWALADHARMIL LIFWALA
Senior Laboratory Manager at Shalby HospitalsSenior Laboratory Manager at Shalby Hospitals
AJAY KUMAR RAOAJAY KUMAR RAO
AVP & Business Head – PAN India at Shalby HospitalsAVP & Business Head – PAN India at Shalby Hospitals
Harsh PatelHarsh Patel
Registered Physiotherapist at Shalby Hospitals - Multi Speciality HospitalRegistered Physiotherapist at Shalby Hospitals - Multi Speciality Hospital
Vimal UsadadiyaVimal Usadadiya
Software Architect at Vagaro Technologies Pvt ltd.Software Architect at Vagaro Technologies Pvt ltd.
Ranvirsinh DabhiRanvirsinh Dabhi
Restaurant Manager at McGettiganRestaurant Manager at McGettigan